AsianScientist reported on the continuous advancements in medical science, with new treatment modalities being researched and introduced rapidly, including for complex diseases like diffuse large B-cell lymphoma (DLBCL). The standard of care for relapsed or refractory DLBCL typically involves intensive treatments such as chemotherapy and haematopoietic stem cell transplantation. Researchers are working on innovative approaches to improve outcomes for patients with this aggressive blood cancer.
Full Article
Loading PerspectiveSplit analysis...
